4Dmedical (ASX:4DX)
ASX announcement history & article coverage
Transparent by design.
Announcments by 4Dmedical (ASX:4DX) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
Application for quotation of securities - 4DX
Addendum to 2026 Notice of Annual General Meeting
Notification of cessation of securities - 4DX
Application for quotation of securities - 4DX
Ceasing to be a substantial holder
Becoming a substantial holder
Notice of Annual General Meeting/Proxy Form
Appendix 4G and Corporate Governance Statement
FY26 Annual Report
4DMedical expands CT:VQ globally as FY26 revenue rises 21%, but auditor qualifies annual report
Initial Director's Interest Notice - CJ
Board transition and key personnel appointments
Ceasing to be a substantial holder
Application for quotation of securities - 4DX
Cleansing Notice
Application for quotation of securities - 4DX
Notification of Date of 2026 AGM
FY2026 Full year results
4DMedical reports FY26 growth with FDA clearance, US reimbursement, and $3B market expansion for CT:VQ™
Appendix 4E - Preliminary Final Report
Application for quotation of securities - 4DX
Cleansing Notice
Application for quotation of securities - 4DX
Update - Proposed issue of securities - 4DX
Update - Proposed issue of securities - 4DX
Quarterly Activity Report and Appendix 4C
4DMedical secures major US commercial deal, expands global footprint, and reports 23% revenue growth in FY26
Change in substantial holding